Radial Extracorporeal Shockwave Therapy (rESWT) for Coccydynia: a Quasi-experimental Case Series
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Barts & The London NHS Trust
- Enrollment
- 14
- Primary Endpoint
- Management of coccydynia
Study Overview
Brief Summary
The aim of this study was to assess whether a pain-adapted protocol of rESWT is effective in treating coccydynia.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Age ≥18 years
- •VAS pain level ≥6
- •Diagnosis of coccydynia (persistent pain in the coccygeal area consistent with coccydynia)
Exclusion Criteria
- •Age <18 years
- •Local or systemic neurological disease
- •Rheumatological disease
- •Malignant disease
- •Previous spinal surgery or spinal disease
- •Coagulopathies
- •Pregnancy
- •VAS pain level <6
- •Recent (≤6 weeks) trauma to the coccyx
Outcomes
Primary Outcomes
Management of coccydynia
Time Frame: 12 months
Management of coccydynia (pain in the coccyx). The main presenting symptom is pain. its management is the primary goal of treatment. The pain VAS was used to monitor patient response and clinical improvement throughout treatment, with patients ranking the severity of their pain at rest, between "no pain" (0) and "worst imaginable pain" (10). Patients were asked their pain level before treatment at each session; although, this did not form part of our formal data collection. Treatment continued until patients reported a VAS pain level ≤3, at which point they were discharged from the clinic.
Secondary Outcomes
No secondary outcomes reported
Investigators
Kabir Singh Lota
Doctor
Barts & The London NHS Trust